Critical limb ischemia

There are 41 papers on critical limb ischemia in aging research: 1 trial and 28 observational studies in people, 4 in animals, 8 reviews.

Disease

41 papers study it23 more mention it6 findings

See all 64 papers on critical limb ischemia

“Individual endpoints including CLI (RR: 0.50, 95% CI: 0.39-0.63, P <0.001)”
Major Adverse Limb Events with Tirzepatide vs. Injectable Semaglutide in Adults with Type 2 Diabetes and Peripheral Artery DiseaseADA Scientific Sessions 2026 abstract2026doi:10.2337/db26-1282-or
  • Human trial1
  • Humans28
  • Animals4

Effects

1

Lifespan

downin humans1

1 study
  1. Critical limb ischemia is linked with lower lifespan in humans (chronic critical limb ischemia) (decreased by 9 years).

    Humanschronic critical limb ischemiamales

Associations

5

Homocitrulline

upin humans1

1 study
  1. Homocitrulline is associated with critical limb ischemia in humans after adjustment for traditional risk factors.

    Humansafter adjustment for traditional risk factors27 yearsn = 3,759

More on Homocitrulline

Circulating metabolites

upin humans1

1 study
  1. Circulating metabolites predict critical limb ischemia in humans (prospective cohort with median follow-up of 27 years) (∆C statistic, 0.041 [95% CI, 0.018-0.064]).

    Humansprospective cohort with median follow-up of 27 years27 yearsn = 3,759

More on Circulating metabolites

Tirzepatide

downin humans1RR 0.5

1 study
  1. Tirzepatide is linked with a lower risk of critical limb ischemia in humans (compared with injectable semaglutide, propensity-matched cohort) (RR 0.50 (95% CI 0.39-0.63)).

    Humanscompared with injectable semaglutide, propensity-matched cohortn = 24,274

More on Tirzepatide

Dementia prevalence

upin humans1+8% prevalence

1 study
  1. Critical limb ischemia is associated with dementia prevalence in humans (critical limb ischemia) (8% prevalence).

    Humanscritical limb ischemian = 369

Mortality

upin humans1

1 study
  1. Critical limb ischemia is associated with mortality in humans (Relative to the Dutch population, adjusted for age and gender) (Mortality rate ratio 3.13 (95% CI 2.00–4.66); 24 deaths).

    HumansRelative to the Dutch population, adjusted for age and genderboth; 27 womensn = 36

Trial sponsors

Funding

2 grants since 2016

Japan Society for the Promotion of Science¥3.9MNational Heart, Lung, and Blood Institute$533K

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 2Mar 2026: 3Apr 2026: 0May 2026: 2Jun 2026: 1Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 0Nov 2026: 012 papers in 12 months

See all 64 papers on critical limb ischemia